VA ECMO for postcardiotomy cardiogenic shock in adults

experts and the committee considered the key efficacy outcomes to be: restoration of organ function and bridging to recovery, transplant or long-term support. 3.6 The professional experts and the committee considered the key safety outcomes to be: bleeding, leg ischaemia, stroke, infection, renal failure and circuit-related complications. 3.7 Patient commentary was sought but none was received. Committee comments 3.8 Clinical experts advised that some centres provide elective VA ECMO for people who are more likely to have PCS, and it is routinely used in some centres. 3.9 Clinical experts advised that VA ECMO can be done either peripherally or centrally. Central VA ECMO is used more commonly after cardiac surgery. 3.10 It would be difficult to do randomised controlled trials in people with PCS. So, other types of data collection such as registries could be useful. 3.11 The recommendations in this guidance include use of VA ECMO during pregnancy or in the postpartum period. 3.12 Clinical experts advised that this procedure could have a better outcome when it is used for post-transplant support because of primary graft dysfunction. 3.13 Some people who had VA ECMO have become organ donors and their organs have been transplanted. 3.14 The committee was told
